BOURRIE, BERNARD,CASELLAS, PIERRE,COSNIER-PUCHEU, SYLVIE,JEGHAM, SAMIR,PERREAUT, PIERRE
申请号：
PH12014502020
公开号：
PH12014502020A1
申请日:
2014.09.10
申请国别(地区):
PH
年份:
2014
代理人:
摘要：
The present invention relates to combinations of N-[2-(2,1,3-benzothiadiazol-5- ylamino)-6-(2,6-dichlorophenyl) pyrido[2,3-d]pyrimidin-7-yl]-N-(1,1-dimethylethyl)-urea and cytarabine and their use for treating AML or CML.
